﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Advanced Pharmaceutical Bulletin</JournalTitle>
      <Issn>2228-5881</Issn>
      <Volume>13</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2023</Year>
        <Month>03</Month>
        <DAY>19</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>In Vitro Efficacy of Curcumin-Loaded Amine-Functionalized Mesoporous Silica Nanoparticles against MCF-7 Breast Cancer Cells</ArticleTitle>
    <FirstPage>317</FirstPage>
    <LastPage>327</LastPage>
    <ELocationID EIdType="doi">10.34172/apb.2023.035</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Mohebian</LastName>
      </Author>
      <Author>
        <FirstName>Mirzaagha</FirstName>
        <LastName>Babazadeh</LastName>
      </Author>
      <Author>
        <FirstName>Nosratollah</FirstName>
        <LastName>Zarghami</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-4236-4537</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/apb.2023.035</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2021</Year>
        <Month>08</Month>
        <Day>09</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2022</Year>
        <Month>01</Month>
        <Day>05</Day>
      </PubDate>
    </History>
    <Abstract>Purpose: Mesoporous silica nanoparticles (MSNs) have drawn substantial interest as drug nanocarriers for breast cancer therapy. Nevertheless, because of the hydrophilic surfaces, the loading of well-known hydrophobic polyphenol anticancer agent curcumin (Curc) into MSNs is usually very low. Methods: For this purpose, Curc molecules were loaded into amine-functionalized MSNs (MSNs-NH2 -Curc) and characterized using thermal gravimetric analysis (TGA), Fourier-transform infrared (FTIR), field emission scanning electron microscope (FE-SEM), transmission electron microscope (TEM), Brunauer-Emmett-Teller (BET). MTT assay and confocal microscopy, respectively, were used to determine the cytotoxicity and cellular uptake of the MSNs-NH2 - Curc in the MCF-7 breast cancer cells. Besides, the expression levels of apoptotic genes were evaluated via quantitative polymerase chain reaction (qPCR) and western blot. Results: It was revealed that MSNs-NH2 possessed high values of drug loading efficiency and exhibited slow and sustained drug release compared to bare MSNs. According to the MTT findings, while the MSNs-NH2 -Curc were nontoxic to the human non-tumorigenic MCF-10A cells at low concentrations, it could considerably decrease the viability of MCF-7 breast cancer cells compared to the free Curc in all concentrations after 24, 48 and 72 hours exposure times. A cellular uptake study using confocal fluorescence microscopy confirmed the higher cytotoxicity of MSNs-NH2 -Curc in MCF-7 cells. Further, it was found that the MSNs-NH2 -Curc could drastically affect the mRNA and protein levels of Bax, Bcl-2, caspase 3, caspase 9, and hTERT relative to the free Curc treatment. Conclusion: Taken together, these preliminary results suggest the amine-functionalized MSNs-based drug delivery platform as a promising alternative approach for Curc loading and safe breast cancer treatment.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Curcumin</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Mesoporous silica nanoparticles</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Drug delivery system</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Breast cancer</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>